{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:38:37Z","timestamp":1791923917246,"version":"4.3.4"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2012,3]]},"abstract":"<jats:p>\n            Primary hyperaldosteronism, one cause of which is aldosterone-producing adenomas (APAs), may account for \u22645% to 10% of cases of essential hypertension. Germline mutations have been identified in 2 rare familial forms of primary hyperaldosteronism, but it has been reported recently that somatic mutations of the\n            <jats:italic>KCNJ5<\/jats:italic>\n            gene, which encodes a potassium channel, are present in some sporadic nonsyndromic APAs. To address this further we screened 2 large collections of sporadic APAs from the United Kingdom and Australia (totalling 73) and found somatic mutations in the selectivity filter of\n            <jats:italic>KCNJ5<\/jats:italic>\n            in 41% (95% CI: 31% to 53%) of the APAs (30 of 73). These included the previously noted nonsynonymous mutations, G151R and L158R, and an unreported 3-base deletion, delI157, in the region of the selectivity filter. APAs containing a somatic\n            <jats:italic>KCNJ5<\/jats:italic>\n            mutation were significantly larger than those without (1.61 cm [95% CI: 1.39\u20131.83 cm] versus 1.04 cm [95% CI: 0.91\u20131.17 cm];\n            <jats:italic>P<\/jats:italic>\n            &lt;0.0001) but with substantial overlap in size between genotypes. The APAs carrying a mutation, but not those without, also consistently lacked a postural aldosterone response, suggesting a physiologically distinct subtype. Hence, somatic\n            <jats:italic>KCNJ5<\/jats:italic>\n            mutations are not restricted to large APAs (&gt;2 cm), and their frequency in our unselected series suggests they are common and could be important in the molecular pathogenesis of many sporadic cases of APA.\n          <\/jats:p>","DOI":"10.1161\/hypertensionaha.111.186239","type":"journal-article","created":{"date-parts":[[2012,1,18]],"date-time":"2012-01-18T06:05:50Z","timestamp":1326866750000},"page":"587-591","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":138,"title":["Somatic Mutations Affecting the Selectivity Filter of KCNJ5 Are Frequent in 2 Large Unselected Collections of Adrenal Aldosteronomas"],"prefix":"10.1161","volume":"59","author":[{"given":"Elena A.B.","family":"Azizan","sequence":"first","affiliation":[{"name":"From the Clinical Pharmacology Unit (E.A.B.A., M.M., M.J.B., K.M.O.), Department of Medicine, Addenbrooke's Hospital, Cambridge, United Kingdom; Endocrine Hypertension Research Centre (M.S., R.G., B.K., S.X.), University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospital, Woolloongabba, Brisbane, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena","family":"Murthy","sequence":"additional","affiliation":[{"name":"From the Clinical Pharmacology Unit (E.A.B.A., M.M., M.J.B., K.M.O.), Department of Medicine, Addenbrooke's Hospital, Cambridge, United Kingdom; Endocrine Hypertension Research Centre (M.S., R.G., B.K., S.X.), University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospital, Woolloongabba, Brisbane, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stowasser","sequence":"additional","affiliation":[{"name":"From the Clinical Pharmacology Unit (E.A.B.A., M.M., M.J.B., K.M.O.), Department of Medicine, Addenbrooke's Hospital, Cambridge, United Kingdom; Endocrine Hypertension Research Centre (M.S., R.G., B.K., S.X.), University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospital, Woolloongabba, Brisbane, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Gordon","sequence":"additional","affiliation":[{"name":"From the Clinical Pharmacology Unit (E.A.B.A., M.M., M.J.B., K.M.O.), Department of Medicine, Addenbrooke's Hospital, Cambridge, United Kingdom; Endocrine Hypertension Research Centre (M.S., R.G., B.K., S.X.), University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospital, Woolloongabba, Brisbane, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"Kowalski","sequence":"additional","affiliation":[{"name":"From the Clinical Pharmacology Unit (E.A.B.A., M.M., M.J.B., K.M.O.), Department of Medicine, Addenbrooke's Hospital, Cambridge, United Kingdom; Endocrine Hypertension Research Centre (M.S., R.G., B.K., S.X.), University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospital, Woolloongabba, Brisbane, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxin","family":"Xu","sequence":"additional","affiliation":[{"name":"From the Clinical Pharmacology Unit (E.A.B.A., M.M., M.J.B., K.M.O.), Department of Medicine, Addenbrooke's Hospital, Cambridge, United Kingdom; Endocrine Hypertension Research Centre (M.S., R.G., B.K., S.X.), University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospital, Woolloongabba, Brisbane, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris J.","family":"Brown","sequence":"additional","affiliation":[{"name":"From the Clinical Pharmacology Unit (E.A.B.A., M.M., M.J.B., K.M.O.), Department of Medicine, Addenbrooke's Hospital, Cambridge, United Kingdom; Endocrine Hypertension Research Centre (M.S., R.G., B.K., S.X.), University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospital, Woolloongabba, Brisbane, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"O'Shaughnessy","sequence":"additional","affiliation":[{"name":"From the Clinical Pharmacology Unit (E.A.B.A., M.M., M.J.B., K.M.O.), Department of Medicine, Addenbrooke's Hospital, Cambridge, United Kingdom; Endocrine Hypertension Research Centre (M.S., R.G., B.K., S.X.), University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospital, Woolloongabba, Brisbane, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneph0626"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2008.01.005"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2005.02.004"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031337"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1198785"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.37.11.831"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3283028352"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2008.04882.x"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1993.tb01690.x"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1991.tb00306.x"},{"key":"e_1_3_4_12_2","first-page":"863","article-title":"TASK (TWIK-related acid-sensitive K+ channel) is expressed in glomerulosa cells of rat adrenal cortex and inhibited by angiotensin II","volume":"14","author":"Czirjak G","year":"2000","unstructured":"Czirjak G, Fischer T, Spat A, Lesage F, Enyedi P . TASK (TWIK-related acid-sensitive K+ channel) is expressed in glomerulosa cells of rat adrenal cortex and inhibited by angiotensin II. Mol Endocrinol. 2000;14:863\u2013874.","journal-title":"Mol Endocrinol"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1210\/mend.16.3.0788"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2003.10.008"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-120-3-903"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0712000105"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7601934"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1202887"},{"key":"e_1_3_4_19_2","first-page":"95","article-title":"G-protein and signalling in pituitary tumours","volume":"71","author":"Lania A","year":"2009","unstructured":"Lania A, Spada A . G-protein and signalling in pituitary tumours. Horm Res. 2009;71:95\u2013100.","journal-title":"Horm Res"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-0775"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI11887"},{"key":"e_1_3_4_22_2","article-title":"Structural correlates of selectivity and inactivation in potassium channels","author":"McCoy JG","unstructured":"McCoy JG, Nimigean CM . Structural correlates of selectivity and inactivation in potassium channels. Biochim Biophys Acta. Epub ahead of print September 16, 2011.","journal-title":"Biochim Biophys Acta"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M307723200"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-36-2-401"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-52-2-195"},{"key":"e_1_3_4_26_2","first-page":"627A","article-title":"Half of an unselected series of aldosterone-producing adenomas have somatic mutation of the KCNJ5 channel and a zona fasciculata profile","volume":"25","author":"Azizan E","year":"2011","unstructured":"Azizan E, Lam B, Hoffman G, Kuc R, Newhouse SJ, Brown MJ . Half of an unselected series of aldosterone-producing adenomas have somatic mutation of the KCNJ5 channel and a zona fasciculata profile. J Hum Hypertens. 2011;25:627A.","journal-title":"J Hum Hypertens"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.111.186239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:45:21Z","timestamp":1715593521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.111.186239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.111.186239"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.111.186239","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"2011-10-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-12-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-01-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}